Mehmet TOTAN, Murat DANACI, Mahmut ÇAKIR, Ali Rıza AK, Şükrü KÜÇÜKÖDÜK

İnvaziv aspergillozisin neden olduğu kosta destrüksiyonu (Olgu sunumu)

Aspergillozis Aspergillus, ailesine ait monomorfik mantarların oluşturduğu bir grup hastalığı ifade eder. İnfeksiyon sporların inhalasyonunu takiben pulmoner form olarak başlar, özellikle immün yetersizliği ve sistemik hastalığı olanlarda invaziv forma dönüşebilir. Altı aydır antitüberküloz tedavi alan bir yaşındaki kız hasta öksürük, ateş ve sol göğüste şişlik şikayetleriyle başvurdu. Akciğer grafisinde sol beşinci kostanın olmadığı görüldü. Kitleden ponksiyonla alınan apse kültüründe aspergillus üretilerek tanı sitopatolojik olarak doğrulandı. Radikal doku eksizyonu ve uygun antifungal tedaviyle iyileşerek taburcu edildi. Bilgilerimize göre bizim olgumuz, aspergillozisin neden olduğu kosta destrüksiyonunu gösteren ilk olgu olduğundan yayınlanmaya değer bulundu.

Destruction of rib due to invasive aspergillosis

Broadly defined, aspergillosis is a group of mycoses with monomorphic fungi of aspergillus species. Infection begins after the inhalation of spors in the pulmonary form and can progress into the invasive form especially in immunocomromise cases and also those with a systemic disease. A one year old girl who was on antituberculosis therapy for six monts admitted to our clinics with fever, cough and swelling on the left chest. On chest-x-ray, the left fifth costa was absent. Aspergillus grew on cultures which were obtained by puncture of the swelling, and diagnosis was cytopathogically supported. After radical excission of the mass and initiation of appropriate antifungal therapy, she was improved and discharged. To our knowledge, our case was considered worthreporting because it is the first that showed destruction of rib due to aspergillosis.

PDF

___

1. Gerson S, Talbot G, Hurwitz S, Strom B. Prolonged granulocytopenia: The majör risk factor for İnvasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345-51.
2. Edge JR, Stansfield D, Fletcher DE, et al. Pulmonary aspergillosis in an unselected hospital population. Chest 1971; 59:407-13.
3. Saral R. Candida and aspergillus İnfections in immunocompromised host: an overview. Rev Infect Dis 1991; 13: 487-92.
4. Binger RE, Falling LJ, Pugatch LD, et al. Chronic necrotizing pulmonary aspergillosis;a discrete clinical entity. Medicine 1982; 61(2): 109-124.
5. Young RC, Bennett JE, Vogel CL, et al. Aspergillosis; The spectrum of the disease in 98 patients. Medicine 1970; 49: 147-73.
6. Walmsley S, Devi S, King S, et al. invasive aspergillus infections in a pediatric hospital; a ten year review. Ped Infect Dis J 1993; 12:673-82.
7. Neijens HJ, Frenkel J. invasive aspergillus infections in granulomatous disease; treatment with itraconasole. J Pediatr l989; 115: 1016.
8. Hillerdal G. Pulmonary infection İnvading the pleura. Thorax 1981; 36(10): 745-1.
9. Golladay ES, Baker SB. İnvasive aspergiilosis in children. J Pediatr Surg 1987; 22:504-5.
10. Schaffner A, Douglas J, Braude A, et al. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to aspergillus. J Clin Invest 1982; 69: 617-31.